New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
MediPharm Labs Corp.
MEDIF
Shape
US Flag

PNK

Unprofitable

Unprofitable

21M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

21M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

0.05USD
Shape-0.00 ( -4.20%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-77%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

30%

Quote Panel

Shape
Updated October 16, 2024
1W -0.47 % 1M 8.02 % 3M -0.94 % 1Y -6.25 %

Key Metrics

Shape
  • Market Cap

    21.25M


  • Shares Outstanding

    404.82M


  • Share in Float

    387.26M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    0.0525


  • Average Volume

    56670


  • Beta

    0.927


  • Range

    0.037-0.075


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.medipharmlabs.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.79x

P/S Ratio

0.59x

P/B Ratio

0.0

Debt/Equity

-36.8%

Net Margin

$-0.0

EPS

How MEDIF compares to sector?

P/E Ratio

Relative Strength

Shape

MEDIF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$54M

Shape448%

2025-Revenue

$0.01

Shape-10%

2025-EPS

$37M

Shape-1099%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.03
vs -0.05

Q3.22

arrow
arrow

N/A

-0.03
vs -0.03

Q4.22

arrow
arrow

N/A

-0.02
vs -0.08

Q1.23

arrow
arrow

N/A

-0.01
vs -0.03

Q2.23

arrow
arrow

N/A

-0.01
vs -0.03

Q3.23

arrow
arrow

N/A

-0.01
vs -0.03

Q4.23

arrow
arrow

N/A

-0.01
vs -0.02

Q1.24

arrow
arrow

N/A

-0.01
vs -0.01

Q2.24

arrow
arrow

N/A

-0.01
vs -0.01

Q3.24

arrow
arrow

N/A

-0.00
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-14%

4.4M  vs 5.1M

Q3.22

arrow
arrow

+34%

7.3M  vs 5.4M

Q4.22

arrow
arrow

-2%

5.6M  vs 5.7M

Q1.23

arrow
arrow

+20%

5.8M  vs 4.9M

Q2.23

arrow
arrow

+120%

9.6M  vs 4.4M

Q3.23

arrow
arrow

+17%

8.5M  vs 7.3M

Q4.23

arrow
arrow

+63%

9.1M  vs 5.6M

Q1.24

arrow
arrow

+67%

9.8M  vs 5.8M

Q2.24

arrow
arrow

+7%

10.3M  vs 9.6M

Q3.24

arrow
arrow

+33%

11.3M  vs 8.5M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-13%

-0.13
vs -0.10

Q3.22

arrow
arrow

-13%

-0.13
vs -0.13

Q4.22

arrow
arrow

-10%

-0.10
vs -0.13

Q1.23

arrow
arrow

-6%

-0.06
vs -0.10

Q2.23

arrow
arrow

-5%

-0.05
vs -0.06

Q3.23

arrow
arrow

-8%

-0.08
vs -0.05

Q4.23

arrow
arrow

-6%

-0.06
vs -0.08

Q1.24

arrow
arrow

-7%

-0.07
vs -0.06

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News